Literature DB >> 25609774

Frequency of ambulatory care adverse events in Latin American countries: the AMBEAS/PAHO cohort study.

Dolors Montserrat-Capella1, Manuel Suárez2, Lidia Ortiz3, José Joaquín Mira4, Hernando Gaitán Duarte5, Ludovic Reveiz6.   

Abstract

OBJECTIVE: Determine the frequency and preventability of adverse events (AEs) from available information sources in selected ambulatory care (AC) sites in Latin America (LA).
DESIGN: Multinational observational cohort was conducted to determine the period prevalence (retrospective focus) and the cumulative incidence (prospective focus) of AEs.
SETTING: Outpatient clinics in Mexico, Peru, Brazil and Colombia. PARTICIPANTS: A random selection of 2080 patients.
INTERVENTIONS: The existence of AE was decided based on trigger information provided by the patient and crossing the data with each patient's medical history. MAIN OUTCOME MEASURES: AE occurrences 6 months prior (prevalence) and 42 days after (incidence) the patient receiving AC were identified. AE type and preventability were also described.
RESULTS: Two thousand eighty patients participated in the study. AEs prevalence was 5.2% (108/2080) [95% confidence interval (CI) 4.2-6.1%], and cumulative incidence was 2.4% (42/1757) (95% CI 1.7-3.1%). AEs considered preventable were 44% (55/108) of prevalence period, and 52.4% (22/42) of incidence period. Preventability was associated with patient socioeconomic status (OR 3.5, 95% CI 1.4-8.8), medication error (OR 0.1, 95% CI 0.0-0.4), diagnostic error (OR 0.1, 95% CI 0.0-0.8) and a minor impact on the patient (OR 0.2 95% CI 0.1-0.9).
CONCLUSION: The frequency of AE in ambulatory settings in LA is in the high-frequency range of research focused on the prevalence of AEs. Fifty percent was preventable. This study provides an approach for assessing the frequency and preventability of AE in order to enhance patient safety in LA.
© The Author 2015. Published by Oxford University Press in association with the International Society for Quality in Health Care; all rights reserved.

Entities:  

Keywords:  Latin America; adverse events; ambulatory care; patient safety; primary care

Mesh:

Year:  2015        PMID: 25609774     DOI: 10.1093/intqhc/mzu100

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  6 in total

1.  Validation of the QualiPresc instrument for assessing the quality of drug prescription writing in primary health care.

Authors:  Almária Mariz Batista; Zenewton André da Silva Gama; Dyego Souza
Journal:  PLoS One       Date:  2022-05-11       Impact factor: 3.752

2.  Design and Testing of the Safety Agenda Mobile App for Managing Health Care Managers' Patient Safety Responsibilities.

Authors:  José Joaquín Mira; Irene Carrillo; Cesar Fernandez; Maria Asuncion Vicente; Mercedes Guilabert
Journal:  JMIR Mhealth Uhealth       Date:  2016-12-08       Impact factor: 4.773

3.  The Second Victim Phenomenon After a Clinical Error: The Design and Evaluation of a Website to Reduce Caregivers' Emotional Responses After a Clinical Error.

Authors:  José Joaquín Mira; Irene Carrillo; Mercedes Guilabert; Susana Lorenzo; Pastora Pérez-Pérez; Carmen Silvestre; Lena Ferrús
Journal:  J Med Internet Res       Date:  2017-06-08       Impact factor: 5.428

4.  Potential value of patient record review to assess and improve patient safety in general practice: A systematic review.

Authors:  Caoimhe Madden; Sinéad Lydon; Ciara Curran; Andrew W Murphy; Paul O'Connor
Journal:  Eur J Gen Pract       Date:  2018-12       Impact factor: 1.904

5.  [Avoidable adverse events in primary care. Retrospective cohort study to determine their frequency and severity].

Authors:  Irene Carrillo; José Joaquín Mira; M Pilar Astier-Peña; Pastora Pérez-Pérez; Johanna Caro-Mendivelso; Guadalupe Olivera; Carmen Silvestre; Aurora Mula; María Ángeles Nuin; Jesús M Aranaz-Andrés
Journal:  Aten Primaria       Date:  2020-06-09       Impact factor: 1.137

Review 6.  Adverse drug reactions in primary care: a scoping review.

Authors:  H Khalil; C Huang
Journal:  BMC Health Serv Res       Date:  2020-01-06       Impact factor: 2.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.